Osteoblastic bone lesions developing during treatment with erlotinib indicate major response in patients with non-small cell lung cancer: a brief report.

Saved in:
Bibliographic Details
Title: Osteoblastic bone lesions developing during treatment with erlotinib indicate major response in patients with non-small cell lung cancer: a brief report.
Authors: Lind JS; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, the Netherlands., Postmus PE, Smit EF
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2010 Apr; Vol. 5 (4), pp. 554-7.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-1380
DOI:10.1097/JTO.0b013e3181d3e47e